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Abstract
Currently, there is no animal model known that mimics natural nasal colonization by Staphylococcus aureus in humans. We
investigated whether rhesus macaques are natural nasal carriers of S. aureus. Nasal swabs were taken from 731 macaques. S.
aureus isolates were typed by pulsed-field gel electrophoresis (PFGE), spa repeat sequencing and multi-locus sequence
typing (MLST), and compared with human strains. Furthermore, the isolates were characterized by several PCRs. Thirty-nine
percent of 731 macaques were positive for S. aureus. In general, the macaque S. aureus isolates differed from human strains
as they formed separate PFGE clusters, 50% of the isolates were untypeable by agr genotyping, 17 new spa types were
identified, which all belonged to new sequence types (STs). Furthermore, 66% of macaque isolates were negative for all
superantigen genes. To determine S. aureus nasal colonization, three nasal swabs from 48 duo-housed macaques were
taken during a 5 month period. In addition, sera were analyzed for immunoglobulin G and A levels directed against 40
staphylococcal proteins using a bead-based flow cytometry technique. Nineteen percent of the animals were negative for S.
aureus, and 17% were three times positive. S. aureus strains were easily exchanged between macaques. The antibody
response was less pronounced in macaques compared to humans, and nasal carrier status was not associated with
differences in serum anti-staphylococcal antibody levels. In conclusion, rhesus macaques are natural hosts of S. aureus,
carrying host-specific lineages. Our data indicate that rhesus macaques are useful as an autologous model for studying S.
aureus nasal colonization and infection prevention.
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Introduction
In the light of the rapid, worldwide emergence of antibiotic
resistance in and the lack of an effective long-term elimination
strategy against Staphylococcus aureus (S. aureus) nasal carriage, new
approaches are needed to prevent staphylococcal carriage and its
consequent diseases. Many different S. aureus animal models have
been described for studying the pathogenesis of S. aureus
colonization and infection. These models have provided insight
into the role of bacterial virulence genes and have assisted in the
estimation of vaccine efficacy. Models have been set up in various
species, such as insects, worms, mice, rats, guinea pigs, hamsters,
chickens, rabbits, sheep, dogs, pigs, and cows [1–4]. Notably, most
of these animals, unlike humans, are not natural nasal carriers of S.
aureus, only pigs, sheep, and cows may be naturally colonized by S.
aureus. For instance, S. aureus sequence type (ST) 398 strains belong
to a biotype associated with pigs and other species of livestock
[5,6]. S. aureus strain RF122 is a member of a bovine mastitis-
associated clone that is genetically different from human clones of
S. aureus [7,8]. Humans can acquire these S. aureus strains during
intensive short-term exposure to livestock, but in most cases the
strain is lost again within 24 hours [9]. However, lack of a natural,
human-like animal model of nasal S. aureus carriage is still a
problem. Therefore, we investigated whether a non-human
primate could provide a natural model for human nasal carriage
of S. aureus.
The rhesus macaque (Macaca mulatta) belongs to the old world
monkeys and has been used in several studies involving S. aureus.
Kuklin et al. used rhesus macaques to study the immunogenicity of
IsdB [10]. Protection against lethal SEB aerosol exposure by
passive transfer of SEB-specific antibodies was also studied in
macaques [11]. In addition to these protection studies, rhesus
macaques were also used for safety evaluations. For example, the
tolerability and potential toxicity of the thrombolytic agent
staphylokinase was investigated in healthy rhesus macaques [12].
To our knowledge, natural nasal S. aureus carriage and the
consequences on natural immunity in rhesus macaques has never
been studied before.
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Using a cross sectional setup, we isolated 287 S. aureus strains
from 731 rhesus macaques after nasal sampling. We compared S.
aureus strains isolated from rhesus macaques and humans.
Furthermore, we followed a group of 48 rhesus macaques in time
for studying persistence of nasal carriage of S. aureus. In addition,
serum samples from these macaques were analyzed for anti-
staphylococcal immunoglobulin G and A (IgG and IgA) levels.
Materials and Methods
Study population
For comparison of S. aureus strains isolated from rhesus
macaques with those from humans, 731 rhesus macaques from
the breeding colony of the Biomedical Primate Research Centre
(Rijswijk, The Netherlands) were studied. These animals were of
Indian, Burmese and Chinese origin. These macaques were
housed in groups of 2–44 individuals. Furthermore, 48 young
rhesus macaques that were recently imported from China were
followed in time for studying the persistence of S. aureus nasal
carriage as well as their serum anti-staphylococcal antibody levels.
These animals were duo-housed in 4 different animal rooms.
Physical contact with the macaques in the neighbouring cage was
possible. In each room 2 groups of cages were located opposite to
each other.
Human S. aureus strains
For reasons of comparison, 56 human isolates of S. aureus were
included. These carriage (n = 30) and bacteremia derived (n= 20)
MSSA isolates have been described before [13,14]. Three MSSA
isolates from animal care-takers and 3 S. aureus strains for which
Figure 1. Dendrogram of the PFGE data of S. aureus strains isolated from rhesus macaques and humans. Blue color indicates S. aureus
strains isolated from rhesus macaques, red color indicates S. aureus strains isolated from humans. Five clusters consisted of only rhesus macaque
isolates, one comprised only human isolates, and five clusters included isolates from both macaques and humans.
doi:10.1371/journal.pone.0026170.g001
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the genome sequence is known were included as well (N315,
Mu50, MRSA252).
Ethics statement
Sampling of the longitudinally screened macaques was ap-
proved by the Animal Experiments committee of the Biomedical
Primate Research Centre (Dierexperimentencommissie (DEC),
which is the ethical committee installed and officially recognised as
required by the Dutch Law on Experimental Animals and which is
the Dutch analogue for the IACUC). The approval number is:
DEC#579, dated October 28, 2008. The study was conducted in
compliance with all relevant Dutch laws and in agreement with
international and scientific standards and guidelines.
Sampling for bacteriology of the animals in the breeding groups
was performed as part of their yearly routine health screening,
which is by Dutch law not considered to be an animal experiment.
Therefore no permission of the ethical committee was necessary
for this part of the study. All samplings were performed under
ketamine anaesthesia (which is routine for all health checks of non-
human primates) and all efforts were made to minimize stress and
suffering of the animals. The housing, care and handling of all
animals were according to the Dutch Law on Experimental
Animals and the European Directive 86/609/EEC. The research
described is in accordance to the Weatherall Report recommen-
dations for good welfare.
Human samples were described before [13,14]. For carriage
isolates and serum samples, volunteers provided written informed
consent and the local Medical Ethics Committee of the Erasmus
Medical Centre Rotterdam approved the study (MEC-2007-106).
For bacteremia derived isolates, S. aureus strains were collected for
routine culture. The Medical Ethics Committee of the Erasmus
Medical Centre Rotterdam approved the study (MEC-2007-106,
addendum 2).
Sampling procedures
A total of 731 macaques were sampled once for nasal carriage of
S. aureus, while another 48 macaques were screened three times
during a 5 month period. Nasal cultures were taken by streaking
both anterior nares using a sterile cotton swab (Swab Transystem,
Greiner Bio One, Alphen aan de Rijn, The Netherlands) during
regular animal medical check-up. All swabs were processed within
24 hours. Nasal swabs were plated on a Columbia sheep blood
agar plate-medium (bioTRADING, Mijdrecht, The Netherlands).
Plates were read after one and two days of incubation at 35uC.
Identification of S. aureus was based on colony morphology and
coagulase plasma test (Becton Dickinson, Breda, The Netherlands)
and confirmed by API Staph (bioMe´rieux, Boxtel, The Nether-
lands).
Pulsed-field gel electrophoresis
Pulsed-field gel electrophoresis (PFGE) of SmaI digested
chromosomal DNA from all S. aureus strains from rhesus macaques
and 56 strains from humans was performed as described
previously [15]. Relatedness among the PFGE profiles was
evaluated with Bionumerics software (version 3.0; Applied Maths,
Ghent, Belgium). A dendrogram was produced using the Dice
coefficient and an unweighted-pair group method using arithmetic
averages (UPGMA). Band tolerance was set at 2.0%.
Anti-staphylococcal antibodies
IgG and IgA antibody levels in serum directed against the
following antigens were semi-quantified: S. aureus proteins
clumping factor A and B (ClfA and ClfB); surface protein G
(SasG); iron-responsive surface determinants A and H (IsdA and
IsdH); fibronectin-binding proteins A and B (FnbpA and FnbpB);
serine-aspartate dipeptide repeat protein D and E (SdrD and
SdrE); staphylococcal enterotoxins A-E, G-J, M-O, Q, and R
(SEA - SEE, SEG - SEJ, SEM - SEO, SEQ, SER); toxic shock
syndrome toxin 1 (TSST-1); chemotaxis inhibitory protein of S.
aureus (CHIPS); staphylococcal complement inhibitor (SCIN);
extracellular fibrinogen-binding protein (Efb); exfoliative toxin A
and B (ETA and ETB); alpha toxin; c hemolysin B (HlgB);
leukocidin (Luk) S-PV, LukF-PV, LukD-PV, and LukE-PV; and
staphylococcal superantigen-like proteins 1, 3, 5, 9, and 11 (SSL1,
SSL3, SSL5, SSL9, and SSL11). Antibodies were semi-quantified
simultaneously in a single multiplex assay using a bead-based flow
cytometry technique (xMap; Luminex Corporation). Methods
have been described elsewhere [14,16,17], with the exception that
a 1:50 dilution of R-phycoerythrin (RPE)-conjugated AffiniPure
goat anti-human secundairy IgA was used. Tests were performed
in independent duplicates, and the median fluorescence intensity
(MFI) values, reflecting semiquantitative antibody levels, were
averaged. In each experiment, control beads (no protein coupled)
were included to determine nonspecific binding. In the event of
nonspecific binding, the nonspecific MFI values were subtracted
from the antigen-specific results.
Serum samples from 47 out of the 48 rhesus macaques from
China were analyzed. Anti-staphylococcal antibody levels in these
sera were compared to those in sera from 20 Dutch healthy
human volunteers [14]. Pooled serum from all rhesus macaques
included in the present study or from humans was used as a
standard.
Table 1. Different spa types found in 108 representative S.
aureus strains isolated from rhesus macaques.
spa type No. of isolates Percentage of isolates
t189 1 0.9
t516 21 19.4
t729 15 13.9
t786 4 3.7
t1814 3 2.8
t4167 new 11 10.2
t4168 new 18 16.7
t4980 new 2 1.9
t4981 new 1 0.9
t5010 new 2 1.9
t5011 new 1 0.9
t5012 new 1 0.9
t5013 new 6 5.6
t5014 new 1 0.9
t5015 new 4 3.7
t5016 new 1 0.9
t5017 new 5 4.6
t5018 new 5 4.6
t5135 new 3 2.8
t5136 new 1 0.9
t5137 new 1 0.9
t5458 new 1 0.9
doi:10.1371/journal.pone.0026170.t001
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DNA isolation
DNA isolation of S. aureus was performed for representative
isolates from each PFGE cluster. Total DNA of S. aureus was
isolated with the QIAamp DNA Mini Kit (QIAGEN, Venlo, The
Netherlands) according to the manufacturer’s instructions, or with
MagNA Pure LC DNA isolation kit III (bacteria, fungi) using the
MagNA Pure LC instrument (Roche Diagnostics, Almere, The
Netherlands) [18].
spa genotyping
PCR for amplification of the S. aureus protein A (spa) repeat
region was performed according to the published protocol [19].
PCR products were purified with the QIAquick PCR Purification
Kit (QIAGEN, Venlo, The Netherlands) and sequenced using two
amplification primers from a commercial supplier (SeqLab,
Goettingen, Germany). The forward and reverse sequence
chromatograms were analyzed with the Ridom StaphType
software (Ridom GmbH, Wu¨rzburg, Germany).
Multi-locus sequence typing
For one representative S. aureus isolate of each spa type, the
sequence type (ST) was determined using multi-locus sequence
typing (MLST) [20]. goeBURST [21], as implement in Phyloviz
software (http://www.phyloviz.net/wiki/), and which used the
same priority rules for linking STs as eBURST but with a global
optimization, was used to infer relatedness between STs.
goeBURST was run on the whole S. aureus MLST database
(http://saureus.mlst.net/; interrogated July 2011) supplemented
Table 2. Relatedness of spa types within each PFGE cluster.
PFGE
cluster
spa types
in PFGE
cluster Repeat succession
1 -
2 t4980 4 - 16 - 21 - 12 - 12 - 17 - 13 - 39 - 13
t5135 210 - 23 - 34 - 34 - 16 - 17 - 34 - 17 - 17 - 23 - 17
3 -
4 t516 8 - 16 - 2 - 25 - 51 - 68 - 2 - 24 - 2 - 24
t5014 15 - 12 - 16 - 16 - 2 - 25 - 34 - 24 - 17 - 24 - 17
t5015 15 - 12 - 16 - 16 - 25 - 25 - 34 - 24 - 17 - 17 - 17
t5017 8 - 34 - 2 - 43 - 34 - 43 - 43 - 16 - 2 - 17 - 83
5 t516 8 - 16 - 2 - 25 - 51 - 68 - 2 - 24 - 2 - 24
t5011 8 - 16 - 16 - 25 - 25 - 34 - 24 - 17 - 17 - 17
t5015 15 - 12 - 16 - 16 - 25 - 25 - 34 - 24 - 17 - 17 - 17
6 t516 8 - 16 - 2 - 25 - 51 - 68 - 2 - 24 - 2 - 24
t729 7 - 12 - 21 - 17 - 13 - 34 - 34 - 34 - 33 - 34
t786 7 - 12 - 21 - 17 - 13 - 34 - 34 - 33 - 34
t1814 7 - 12 - 21 - 17 - 34 - 34 - 34 - 33 - 34
t5012 8 - 34 - 2 - 43 - 34 - 43 - 43 - 16 - 2 - 17 - 16
t5136 4 - 2 - 17 - 17 - 34 - 24 - 17 - 17 - 17
t5458 210 - 23 - 34 - 17 - 34 - 22 - 34 - 17 - 23 - 34
7 t4167 7 - 23 - 17 - 22 - 249 - 12 - 117 - 24 - 25 - 17
t4168 8 - 23 - 21 - 17 - 13 - 13 - 13 - 24 - 23
t4980 4 - 16 - 21 - 12 - 12 - 17 - 13 - 39 - 13
t5013 7 - 23 - 23 - 17 - 34 - 21 - 12 - 20 - 24
t5016 8 - 34 - 2 - 43 - 34 - 43 - 17 - 83
t5017 8 - 34 - 2 - 43 - 34 - 43 - 43 - 16 - 2 - 17 - 83
t4981 8 - 16 - 2 - 43 - 17 - 34
t5018 8 - 16 - 2 - 43 - 17 - 173 - 34 - 17 - 34
8 t4168 8 - 23 - 21 - 17 - 13 - 13 - 13 - 24 - 23
t5010 8 - 23 - 12 - 17 - 13 - 13 - 13 - 24 - 23
9 t4167 7 - 23 - 17 - 22 - 249 - 12 - 117 - 24 - 25 - 17
t4168 8 - 23 - 21 - 17 - 13 - 13 - 13 - 24 - 23
t5015 15 - 12 - 16 - 16 - 25 - 25 - 34 - 24 - 17 - 17 - 17
t5137 4 - 16 - 13
10 t4168 8 - 23 - 21 - 17 - 13 - 13 - 13 - 24 - 23
11 t189 7 - 23 - 12 - 21 - 17 - 34
doi:10.1371/journal.pone.0026170.t002
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with STs of rhesus macaque isolates not present in the S. aureus
MLST database at the time of interrogation. Clonal complexes
(CCs) are defined as STs that are linked through single locus
variants (SLVs) and are named on the basis of the predicted
founder ST, which is the ST having the most SLVs.
Staphylococcal antigen PCRs
Methicillin resistance was detected with mecA-specific primers
[22]. Six sets of multiplex PCRs were established to amplify 19
superantigen genes (sea to see, seg to ser, seu, tst), eta, etd and agr-1 to -
4, as described previously [23]. The presence of the scn, chp, clfA,
clfB, efb, fnbA, fnbB and tst genes was determined by PCR as well
[13,24–26].
Statistical analysis
Statistical analyses were performed with SPSS software, version
15.0 (SPSS). The Mann-Whitney U test was used to compare
median differences in anti-staphylococcal antibody levels. Differ-
ences were considered statistically significant when 2-sided P-
values were ,0.05.
Results
Characterization of S. aureus isolates in rhesus macaques
A total of 731 macaques was screened once for presence of S.
aureus in their nasal cavity. Thirty-nine percent (287/731) of these
cultures were positive for S. aureus, clearly indicating that rhesus
macaques can be S. aureus nasal carriers.
S. aureus isolates from the 287 culture positive macaques as well
as all collected isolates from the 48 macaques that were sampled
three times (a total of 355 isolates) were typed using molecular
methods including PFGE. This revealed 11 major clusters
(Figure 1). Five of these consisted of only rhesus macaque isolates,
one comprised only human isolates, while five clusters included
isolates from both macaques and humans.
For further characterization of the S. aureus isolates from rhesus
macaques, spa genotyping was performed on representative
isolates from each PFGE cluster (n = 108) (Table 1). These isolates
were all spa-positive, re-confirming that these were indeed S. aureus
strains. This revealed 22 different spa types, of which five have
already been described before. Consequently, we identified 17 new
spa types not included in the Ridom SpaServer database at the
Figure 2. Partial population snapshot of S. aureus. This snapshot was created by goeBURST v1.2 software using the dataset downloaded from
http://saureus.mlst.net/ that included 2010 STs representing 3887 isolates. A subset of this dataset (1304 STs, representing 2875 isolates) is
presentend in this figure including all major Clonal Complexes (CCs) supplemented with all rhesus macaque ST as far as they were not part of the
major CCs. The area of each circle in the goeBURST diagram corresponds to the relative abundance of the STs in the input data. The names of major
CCs have been indicated. ST colors refer to the source S. aureus was isolated from. STs representing macaque isolates are indicated in blue and by
their ST number; brown colors correspond with community-acquired human isolates; red colors correspond with hospital-acquired human isolates;
green colors correspond with animal isolates; yellow colors correspond with S. aureus isolates from food; grey, light green, and light blue colors
correspond with isolates with unknown source.
doi:10.1371/journal.pone.0026170.g002
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time of analysis. These new spa types comprised 59% of the
isolates. The most prominent clone was t516, which comprised 21
isolates (19%). Spa types t4168, t729 and t4167 were represented
by 18 (17%), 15 (14%) and 11 (10%) isolates, respectively. Nine spa
types were present as single isolates. Each major PFGE cluster
comprised 1 to 8 different spa types, though the repeat succession
of different spa types within a cluster were clearly related in some
cases (Table 2).
For one S. aureus isolate of each spa type, we performed MLST
and compared STs found in macaque strains with all STs available
in the S. aureus MLST database at the moment of interrogation
(Figure 2). Seventeen different STs were found, which were all not
present in the S. aureus MLST database at the time of
interrogation. ST2099, ST2100 and ST2134 were part of
CC45, which mostly contained STs found in human S. aureus
isolates. ST2099 and ST2100 were SLVs. Isolates with these 3 STs
were found in different PFGE clusters. ST2094 had relations with
STs in CC1, which contained a lot of STs found in human isolates
as well. The PFGE pattern of this S. aureus isolate differed from all
other macaque isolates, as this isolate was found in PFGE cluster
11, in which this isolate was the only one from macaque origin. All
other STs found in the macaque isolates (ST1760, ST1761,
ST1768, ST2095, ST2096, ST2097, ST2098, ST2105, ST2106,
ST2107, ST2108, ST2119, ST2120) were not part of the larger
Table 3. Presence of genes encoding superantigens, exfoliative toxins, and agr types in 32 representative S. aureus strains isolated
from rhesus macaques.
Genea
Isolate no. seg sei sem sen seo etd agr-1 agr-2 agr-3 agr-4
Gene
profile
PFGE
cluster
Origin isolates
in PFGE clusterb
08-1178 2 2 2 2 2 2 + 2 2 2 1 5 RM
08-1192 2 2 2 2 2 2 + 2 2 2 1 4 RM
08-1276 2 2 2 2 2 2 + 2 2 2 1 7 RM
08-1494 2 2 2 2 2 2 + 2 2 2 1 7 RM
08-1495 2 2 2 2 2 2 + 2 2 2 1 7 RM
08-1185 + + + + + 2 + 2 2 2 2 8 RM
08-1415 + + + + + 2 + 2 2 2 2 8 RM
08-1197 + 2 2 2 2 2 2 2 2 + 3 6 RM+HV
08-1255 + 2 2 2 2 2 2 2 2 2 4 11 RM+HV
08-1299 2 2 2 2 2 2 2 2 2 + 5 5 RM
08-1514 2 2 2 2 2 2 2 2 2 + 5 5 RM
08-1332 2 2 2 2 2 2 2 + 2 2 6 4 RM
08-1342 2 2 2 2 2 2 2 2 + 2 7 6 RM+HV
08-1404 2 2 2 2 2 2 2 2 2 2 8 5 RM
08-1412 2 2 2 2 2 2 2 2 2 2 8 6 RM+HV
08-1423 2 2 2 2 2 2 2 2 2 2 8 7 RM
08-1430 2 2 2 2 2 2 2 2 2 2 8 7 RM
08-1432 2 2 2 2 2 2 2 2 2 2 8 7 RM
08-1487 2 2 2 2 2 2 2 2 2 2 8 6 RM+HV
08-1504 2 2 2 2 2 2 2 2 2 2 8 7 RM
08-1507 2 2 2 2 2 2 2 2 2 2 8 7 RM
08-1528 2 2 2 2 2 2 2 2 2 2 8 7 RM
08-1737 2 2 2 2 2 2 2 2 2 2 8 2 RM+HV
08-1749 2 2 2 2 2 2 2 2 2 2 8 7 RM
08-1756 2 2 2 2 2 2 2 2 2 2 8 7 RM
08-1419 2 2 2 2 2 + 2 2 + 2 9 7 RM
08-1420 2 2 2 2 2 + 2 2 + 2 9 7 RM
08-1486 + 2 + + + 2 2 2 2 2 10 7 RM
08-1583 + + + + + 2 2 2 2 2 11 6 RM+HV
08-1602 + + + + + 2 2 2 + 2 12 9 RM+HV
08-1765 + + + + + 2 2 2 + 2 12 7 RM
08-1630 2 2 2 2 2 + 2 2 2 2 13 2 RM+HV
No. of positive
isolates (%)
8 (25) 5 (16) 6 (19) 6 (19) 6 (19) 3 (9) 7 (22) 1 (3) 5 (16) 3 (9)
aAll isolates were negative for sea, seb, sec, sed, see, seh, sej, sek, sel, sep, seq, ser, seu, tst, and eta.
bIsolates belong to typically rhesus macaque (RM) PFGE clusters or to mixed clusters including both macaque and healthy human volunteer (HV) strains.
doi:10.1371/journal.pone.0026170.t003
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CCs, but were present as singletons. ST1760 and ST2096 as well
as ST1768 and ST2095 were SLVs, and were both found in PFGE
clusters 7 and 6, respectively, clusters with mainly isolates from
macaques. Isolates with STs present as a singleton were distributed
among PFGE clusters 4 to 9, which were clusters with mainly
isolates from rhesus macaques.
Next, we determined the genomic presence of mecA, 19
superantigen genes, and eta and etd by PCR. None of the 108
selected isolates harboured the mecA gene, which indicates that
none of these isolates were MRSA. Thirty-two isolates that were
representative for each spa type were selected for testing presence
of superantigen genes and eta and etd (Table 3). These genes were
absent in 66% (21/32) of these isolates. The etd gene was detected
in 9% of the isolates (3/32), 16% of the isolates were sei-positive
(5/32), 19% were positive for sem, sen, and seo (6/32), and 25%
were positive for seg (8/32). Genes encoding SEA to SEE, SEH,
SEJ to SEL, SEP to SER, SEU, TSST-1 and ETA were absent in
all 32 isolates. Only 6 isolates harboured a complete or incomplete
egc locus. Four of these were strains from PFGE clusters comprising
only macaque isolates, while 2 isolates belong to clusters including
both macaque and human isolates.
These 32 isolates were also agr genotyped (Table 3). The most
common agr type was type I (22%), followed by agr type III (16%),
type IV (9%), and type II (3%). Sixteen isolates (50%) did not
belong to any of the 4 known agr types, which is intriguing. Isolates
with agr type I or type II belonged to PFGE clusters comprising
only macaque isolates, while isolates with other agr types belonged
to clusters including both macaque and human isolates. Overall,
13 combinations of agr type and toxin genes were found. Two of
the agr type I isolates, two of the agr type III isolates and two of the
unknown agr type isolates harboured a complete or incomplete egc
locus. Five agr type I isolates, the single agr type II isolate, one agr
type III isolate, two agr type IV isolates, and 12 isolates with an
unknown agr type harboured none of the superantigen and
exfoliative toxin genes. S. aureus isolates with the same agr type and
toxin genes were distributed among the different PFGE clusters.
S. aureus nasal carriage in rhesus macaques
Forty-eight (4 groups of 12) macaques were screened three times
for nasal carriage of S. aureus over a 5 month period. The four
groups of twelve macaques were housed in separate rooms. For 9
macaques (18.8%), all nasal culture results were negative. Eighteen
macaques (37.5%) had one positive culture, 13 (27.1%) had two
positive cultures, and for 8 macaques (16.7%) S. aureus was found
in all three cultures.
Isolates from these 48 duo-housed macaques were also typed by
PFGE, and spa types were determined for representative isolates
from each PFGE cluster (Figure 3). In macaques with more than
one S. aureus positive nasal culture, a strain replacement occurred
in half of the animals.
It seemed that there was one most prevalent ‘‘epidemic’’ strain
in each animal room. This strain spread from one or a couple of
macaques to most others. This phenomenon was clear for rooms 1
(PFGE type B, spa type t5013), 2 (PFGE type D, spa type t5016)
and 3 (PFGE type C9, spa type t5018), while for room 4, the
epidemic strain was less clear (PFGE type A, spa type t5013, or
PFGE type F, spa type t4167). In some cases, a macaque did not
acquire the epidemic strain, e.g. the macaque in animal room 2,
cage 6 had two nasal cultures positive with a S. aureus isolate with
PFGE type C9, while the epidemic isolate had PFGE type D.
Anti-staphylococcal antibodies in rhesus macaques
Serum samples from 47 of the 48 macaques that were screened
thee times for nasal carriage were analyzed for anti-staphylococcal
antibodies directed against 40 different S. aureus proteins. The MFI
values reflecting the serum IgG and IgA levels for each macaque
and each antibody isotype are shown in Figure 4. An extensive
diversity in individual antibody responses was observed, similar to
the findings in humans. Individual macaques had high antibody
levels against a number of antigens, while anti-staphylococcal
antibody levels against other antigens were low.
For most antigens, there was no apparent quantitative
difference in antibody level between macaques with 0, 1, 2, or 3
positive cultures. However, the median serum levels of IgG
directed against ClfA were significantly higher in rhesus macaques
with one positive culture than in those without positive culture
(MFI value, 657 vs. 191; P,0.05). Additionally, median IgA levels
were higher in macaques without a positive culture than in those
with three positive cultures for LukF (532 vs. 167; P,0.05). In
macaques with three positive cultures, median IgA levels were
higher than in macaques without positive culture for SdrE (881 vs.
200; P,0.05). In macaques with one positive culture, median IgA
levels were higher than in macaques with three positive cultures
for LukD (1580 vs. 599; P,0.005), SEC (658 vs. 23; P,0.05), and
SSL11 (204 vs 22; P,0.05). In general, a larger number of positive
cultures was not related to elevated or decreased anti-staphylo-
coccal antibody levels. Other comparisons were also made (non-
carriers vs. intermittent vs. persistent carriers; carriers of the most
prominent isolate in the animal room vs. carriers of another
isolate). Again, no association was found between nasal carrier
status and anti-staphylococcal antibody levels in serum (data not
shown).
Isolates from rhesus macaques differ from those from humans in
PFGE type, spa type, agr type, and prevalence of superantigen
genes. To determine whether these different S. aureus isolates
induce different humoral antibody responses, anti-staphylococcal
antibody levels in sera of the 47 rhesus macaques were compared
to those in sera of 20 healthy human volunteers (Figure 5).
Significant differences in anti-staphylococcal IgG and IgA levels
between rhesus macaques and healthy volunteers were observed
for 29 and 25 out of 40 antigens, respectively (Table 4). In general,
the median antibody serum levels in humans were higher than
those in macaques. However, the median serum IgG level directed
against SSL1 and SSL5 was significantly higher in macaques than
in humans. The median serum IgA level directed against SSL9
was significantly higher in macaques than in humans.
Association of anti-staphylococcal antibody levels with
presence of genes
To study whether the low antibody levels in rhesus macaques
were due to absence of the genes encoding the antigens, 10 isolates
from the macaques that were screened three times, were selected
Figure 3. Persistence of S. aureus nasal carriage in rhesus macaques. Macaques were duo-housed. Physical contact to the macaques in the
neighbouring cage was possible. Each block indicates an animal room, horizontal lines in blocks indicate which macaques were not able to have
physical contact. Red color indicates the ‘‘epidemic’’ strain in each room. – indicates a S. aureus negative nasal culture. * indicates that the isolate was
not spa genotyped itself, spa type was derived from typed isolates with identical PFGE pattern. 1 indicates that the isolate was not spa genotyped,
and this could not be derived from typed isolates with identical PFGE pattern. S. aureus strains were frequently exchanged between macaques in the
same room.
doi:10.1371/journal.pone.0026170.g003
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Figure 4. Relation between S. aureus nasal colonization and level of anti-staphylococcal IgG (A) and IgA (B). Antibody levels are
reflected by Median fluorescence intensity (MFI) value. Each symbol represents a single rhesus macaque. Blue diamonds represent macaques without
S. aureus positive culture, red triangles represent macaques with one positive culture, green squares represent macaques with two positive cultures,
and black circles represent macaques with three positive cultures. Median values are indicated by horizontal lines. Arrows indicate statistically
significant differences in median values (Mann-Whitney U test). More S. aureus positive cultures were not related to high – or low – anti-
staphylococcal antibody levels. CHIPS, chemotaxis inhibitory protein of S. aureus; Clf, clumping factor; Efb, extracellular fibrinogen-binding protein;
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for determination of the presence of genes encoding antigens
against which a low MFI value was found in macaques, while MFI
values in humans were high (SCIN, CHIPS, ClfA, ClfB, Efb,
TSST-1, FnbpA, and FnbpB). Results are shown in Table 5. None
of the isolates from rhesus macaques were scn-, tst-, or fnbB-
positive, which explains why antibody levels were at background
level. On the other hand, all 10 isolates were clfB- and efb-positive,
and the macaques that carry these isolates had high antibody levels
against these antigens. Nine out of 10 S. aureus isolates did not
possess the gene encoding for CHIPS, which explains why the
MFI values were at background level. The macaque from which
the chp-positive strain was isolated also had MFI values at
background level. Eight isolates were clfA-positive, with corre-
sponding high MFI values for 6 macaques. Interestingly, the two
macaques from which the clfA-negative strains were isolated, still
had high MFI values. Nine isolates possessed the gene encoding
FnbpA, which corresponds with MFI values just above back-
ground level (range 22–616). However, the macaque with the fnbA-
negative S. aureus strain had MFI values above background level as
well. These differences are probably due to a previous exposure to
an other S. aureus strain.
Discussion
Nasal carriage of S. aureus plays a key role in the epidemiology
and pathogenesis of staphylococcal infections [27,28]. Eradication
of S. aureus from the nose has proven to be effective in the
reduction of staphylococcal infections [29–32]. This indicates that
the anterior nasal region is a primary ecological reservoir of S.
aureus [33,34], although throat and perineum are important
reservoirs as well [35–37]. However, nasal re-colonization may
occur within weeks to months in those who have successfully been
decolonized [38,39]. In order to develop new strategies in
prevention of staphylococcal disease, acquiring additional knowl-
edge about the underlying mechanisms of S. aureus nasal carriage is
important. Artificial inoculation of human volunteers offers
opportunities to study these mechanisms [40]. While such semi-
clinical studies in humans remain the most informative, animal
models of S. aureus colonization sometimes enable a more detailed
investigation of the processes involved in pathogenesis by allowing
for more risky interventions.
In the present study, we describe for the first time natural nasal
S. aureus carriage in rhesus macaques. The nasal cavity of these
macaques appears to be an important reservoir of S. aureus, as is
also observed in humans. In a single screening of their noses, 39%
of the 731 rhesus macaques had a positive culture, which is
comparable to the human situation with ,20% persistent carriers
and ,30% intermittent carriers [28,41,42]. Most of these S. aureus
isolates were different from human S. aureus isolates: rhesus
macaque isolates formed separate PFGE clusters, 59% had one of
the 17 spa types that were not yet described, the previously
described spa types t189, t516, t729, t786, and t1814 were rare as
well (Ridom SpaServer), in most macaque isolates genes encoding
superantigens were not present, and half of the isolates could not
be agr typed. Moreover, in the majority of macaque isolates new
STs were found which were not related to described STs. Three
isolates were part of CC45, and one was part of CC1. These
macaque isolates were therefore more comparable to human
isolates than the other ones. Differences between macaque and
human S. aureus isolates are underlined by major differences in
both anti-staphylococcal antibody levels and gene content of the S.
aureus isolates between these two species. This indicates that new
host-specific lineages of S. aureus have now been found in rhesus
macaques.
In contrast to the macaque S. aureus isolates, most human strains
harbour at least one gene encoding superantigens, on average 5 or
6 genes, among which those encoding the egc superantigens SEG,
SEI, SEM, SEN, and SEO are most prevalent [23,43,44]. These
genes were also most prevalent in the macaque isolates. The
relatively low number of isolates containing superantigen genes
could also be due to the fact that the primers used in this study
were designed for S. aureus strains isolated from humans.
Therefore, it can not be concluded that most macaque S. aureus
isolates do not carry superantigen genes at all, but that, at least, if
they are present, these genes differ from those found in human S.
aureus isolates.
In addition, half of the macaque isolates could not be typed with
the current agr multiplex PCR system. Of those that could be
typed, most belonged to agr types I or III, which is in contrast to
human S. aureus isolates. These agr types are also the largest groups
(agr type I 35% and type III 38%), but 25% of the isolates contains
agr type II [45]. In contrast, agr type IV is hardly found among
human isolates (2%), while 19% of the typeable macaque isolates
harboured this type. The agr untypeable S. aureus isolates probably
have a deletion of the agr locus or extensive sequence variation at
the primer sites and could therefore not be typed. This further
emphasizes that S. aureus isolates in rhesus macaques differ from
those in humans.
Next, we studied the persistence of nasal S. aureus carriage in 48
rhesus macaques. PFGE and spa typing of these isolates, as well as
the absence of certain antigen genes while serum anti-staphylo-
coccal antibody levels against these antigens were high, suggest
that persistent nasal S. aureus carriage as observed in humans is not
present among these rhesus macaques. Human persistent carriers
are usually colonized by the same S. aureus strain over a long time
period [46], while half of the studied rhesus macaques carried
different S. aureus isolates, even over a 5 month period. Frequent
transmission of S. aureus isolates rather than persistent nasal
carriage was suggested by the presence of one or two epidemic
strains in each animal room.
The absence of persistent nasal carriage was underlined by the
absence of an association between nasal carrier status and anti-
staphylococcal antibody levels in serum of rhesus macaques, as was
observed in humans. Differences in IgG levels between human
persistent carriers and non-carriers were reported for alpha
hemolysin, major autolysin, IsdA and IsdH, immunodominant
secretory antigen A (IsaA), major histocompatibility complex class
II analogue protein w (Map-w), ClfB, TSST-1, and SEA. IgA
levels were different between persistent carriers and non-carriers
for TSST-1, SEA, ClfA, and ClfB [14,47,48].
In addition, the differences in anti-staphylococcal antibody
levels in rhesus macaques and humans, independent of nasal
carrier status, again underlined the differences between S. aureus
isolates in humans and those in macaques. The major immuno-
genic proteins in human S. aureus strains do not seem to elicit a
humoral immune response in rhesus macaques.
In conclusion, the present study demonstrates that rhesus
macaques are natural hosts of S. aureus, and that S. aureus isolates
ET, exfoliative toxin; Fnbp, fibronectin-binding protein; HlgB, c hemolysin B; Isd, iron-responsive surface determinant; Luk, leukocidin; SasG, S. aureus
surface protein G; SCIN, staphylococcal complement inhibitor; Sdr, serine-aspartate dipeptide repeat protein; SE, staphylococcal enterotoxin; SSL,
staphylococcal superantigen-like protein; TSST-1, toxic shock syndrome toxin 1.
doi:10.1371/journal.pone.0026170.g004
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Figure 5. Level of anti-staphylococcal IgG (A) and IgA (B) in rhesus macaques and human volunteers. Antibody levels are reflected by
Median fluorescence intensity (MFI) value. Each symbol represents a single rhesus macaque or human. Blue squares represent healthy rhesus
macaques and red diamonds represent healthy human volunteers. Median values are indicated by horizontal lines. Arrows indicate statistically
significant differences in median values (Mann-Whitney U test). Anti-staphylcoccal IgG and IgA levels were significantly different between rhesus
macaques and humans for 29 and 25 out of 40 antigens, respectively. CHIPS, chemotaxis inhibitory protein of S. aureus; Clf, clumping factor; Efb,
extracellular fibrinogen-binding protein; ET, exfoliative toxin; Fnbp, fibronectin-binding protein; HlgB, c hemolysin B; Isd, iron-responsive surface
determinant; Luk, leukocidin; SasG, S. aureus surface protein G; SCIN, staphylococcal complement inhibitor; Sdr, serine-aspartate dipeptide repeat
protein; SE, staphylococcal enterotoxin; SSL, staphylococcal superantigen-like protein; TSST-1, toxic shock syndrome toxin 1.
doi:10.1371/journal.pone.0026170.g005
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from rhesus macaques versus those from humans differ in many
aspects. Therefore, rhesus macaques are not suitable for studying
S. aureus persistent carriage as is seen in humans. However, the
nasal cavity is an important reservoir in both species, which
implies that the rhesus macaque provides an interesting model for
studying short term nasal colonization, and in particular bacterial
Table 4. Median fluorescence intensity (MFI) values reflecting antigen-specific IgG and IgA levels in rhesus macaques (RM) and
healthy human volunteers (HV).
MFI value, median (range) MFI value, median (range)
S. aureus protein
(antibody isotype) RM HV Pa
S. aureus
protein
(antibody
isotype) RM HV Pa
alpha toxin (IgG) 14337 (7438–15574) 14587 (6355–17465) 0.285 SEA (IgG) 88 (17–3565) 3839 (29–11365) ,0.001
alpha toxin (IgA) 1540 (139–4729 1775 (215–9549) 0.154 SEA (IgA) 16 (1–449) 247 (5–9345) ,0.001
CHIPS (IgG) 20 (0–2580) 13310 (2933–16281) ,0.001 SEB (IgG) 34 (0–2836) 4223 (190–13622) ,0.001
CHIPS (IgA) 1 (0–130) 7494 (957–11238) ,0.001 SEB (IgA) 2 (0–673) 90 (2–398) ,0.001
ClfA (IgG) 454 (16–8250) 4029 (670–13449) ,0.001 SEC (IgG) 4551 (1–14006) 12720 (4713–15884) ,0.001
ClfA (IgA) 580 (4–6237) 673 (145–4730) 0.373 SEC (IgA) 280 (0–4896) 600 (63–3943) 0.004
ClfB (IgG) 1066 (65–7518) 7272 (2499–14127) ,0.001 SED (IgG) 84 (3–533) 800 (33–7924) ,0.001
ClfB (IgA) 1232 (0–6962) 2357 (255–10038) 0.125 SED (IgA) 1 (0–85) 19 (0–736) ,0.001
Efb (IgG) 622 (162–6325) 4238 (770–12855) ,0.001 SEE (IgG) 3 (0–229) 258 (7–3017) ,0.001
Efb (IgA) 69 (0–1575) 4775 (257–8125) ,0.001 SEE (IgA) 0 (0–151) 12 (0–1856) ,0.001
ETA (IgG) 156 (10–5670) 234 (16–14891) 0.217 SEG (IgG) 37 (0–3861) 517 (5–4385) 0.002
ETA (IgA) 30 (1–366) 19 (6–1127) 0.742 SEG (IgA) 5 (0–353) 22 (0–432) 0.035
ETB (IgG) 72 (0–10405) 55 (1–2855) 0.515 SEH (IgG) 1282 (0–10804) 1400 (9–15602) 0.468
ETB (IgA) 3 (0–1023) 20 (1–1529) 0.026 SEH (IgA) 88 (0–2083) 44 (0–2158) 0.821
FnbpA (IgG) 208 (20–3374) 1269 (222–6132) ,0.001 SEI (IgG) 4 (0–5154) 257 (0–3544) ,0.001
FnbpA (IgA) 73 (1–1047) 744 (26–5261) ,0.001 SEI (IgA) 0 (0–111) 8 (0–840) ,0.001
FnbpB (IgG) 111 (9–1089) 478 (54–2758) ,0.001 SEJ (IgG) 105 (5–7274) 2538 (95–16246) ,0.001
FnbpB (IgA) 15 (2–253) 253 (19–2603) ,0.001 SEJ (IgA) 1 (0–217) 25 (0–2236) ,0.001
HlgB (IgG) 8519 (2595–10365) 10761 (2979–13212) 0.001 SEM (IgG) 12 (0–7325) 307 (8–2738) ,0.001
HlgB (IgA) 474 (10–2799) 556 (44–6394) 0.233 SEM (IgA) 1 (0–354) 56 (0–1128) ,0.001
IsdA (IgG) 2811 (508–8602) 2665 (576–5183) 0.732 SEN (IgG) 7 (0–1166) 631 (0–2672) ,0.001
IsdA (IgA) 248 (13–3997) 357 (9–8058) 0.940 SEN (IgA) 0 (0–155) 7 (0–2743) ,0.001
IsdH (IgG) 929 (44–8170) 3921 (605–9420) ,0.001 SEO (IgG) 40 (7–2009) 306 (147–653) ,0.001
IsdH (IgA) 311 (3–4328) 294 (43–2117) 0.661 SEO (IgA) 3 (0–117) 20 (4–544) ,0.001
LukD (IgG) 1082 (1852–15031) 12226 (3781–16731) 0.011 SEQ (IgG) 5 (0–7125) 341 (0–3763) ,0.001
LukD (IgA) 641 (0–3418) 694 (106–4088) 0.753 SEQ (IgA) 0 (0–132) 19 (0–2219) ,0.001
LukE (IgG) 12386 (5270–14191) 12541 (5955–15590) 0.732 SER (IgG) 3 (0–1797) 63 (0–2654) ,0.001
LukE (IgA) 1181 (28–5431) 664 (38–7766) 0.524 SER (IgA) 0 (0–40) 9 (0–357) 0.001
LukF (IgG) 7321 (1240–12631) 10579 (2984–14996) 0.007 SSL1 (IgG) 8783 (1520–14022) 4683 (518–11914) 0.005
LukF (IgA) 321 (0–2554) 433 (38–3916) 0.041 SSL1 (IgA) 198 (0–4066) 195 (6–2947) 0.956
LukS (IgG) 10470 (1939–14385) 8734 (1662–16976) 0.135 SSL11 (IgG) 867 (43–8824) 1107 (122–8955) 0.311
LukS (IgA) 602 (0–6321) 1015 (13–10014) 0.524 SSL11 (IgA) 46 (3–1495) 96 (8–2162) 0.215
SasG (IgG) 89 (3–3376) 197 (3–2791) 0.093 SSL3 (IgG) 7280 (898–12949) 7813 (1618–15432) 0.403
SasG (IgA) 8 (0–5408) 33 (4–3950) 0.009 SSL3 (IgA) 321 (5–3062) 519 (24–5234) 0.244
SCIN (IgG) 187 (5–7259) 11333 (7572–15438) ,0.001 SSL5 (IgG) 4138 (621–9547) 3267 (511–5928) 0.021
SCIN (IgA) 14 (0–1220) 2945 (211–10036) ,0.001 SSL5 (IgA) 97 (6–1293) 115 (27–933) 0.264
SdrD (IgG) 233 (17–2844) 1683 (400–6924) ,0.001 SSL9 (IgG) 11968 (4788–13605) 9255 (1005–15161) 0.150
SdrD (IgA) 64 (3–2205) 634 (48–4758) ,0.001 SSL9 (IgA) 444 (35–3523) 138 (20–1158) 0.001
SdrE (IgG) 250 (28–6655) 2045 (251–8626) ,0.001 TSST-1 (IgG) 32 (4–9350) 12051 (0–16927) ,0.001
SdrE (IgA) 218 (0–3017) 604 (28–3650) 0.015 TSST-1 (IgA) 4 (0–125) 932 (10–3504) ,0.001
aDifferences in antigen-specific MFI values between groups were considered to be statistically significant at P,0.05 (Mann-Whitney U test).
doi:10.1371/journal.pone.0026170.t004
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factors involved in adherence. Furthermore, rhesus macaque
provide an autologous system in which transmission of S. aureus
strains between individuals can be studied, and are therefore a
useful model for studying infection prevention. Whether data from
these studies can be directly extrapolated to humans is unclear.
However, possibilities for extrapolation from rhesus macaque to
human appear reasonable because of their close evolutionary
relatedness.
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